Corbus Pharmaceuticals Holdings CRBP
NASDAQ CRBP
$4.13 -0.15 (-3.62%)
At close: Oct 22, 2026 · 4:00 PM EDT

Corbus Pharmaceuticals Holdings (CRBP) Share-based Compensation (2013 - 2025)

Updated

Corbus Pharmaceuticals Holdings (CRBP) posted Share-based Compensation of $1.58 million for Q3 2025, down 29.5% from $2.24 million a year earlier but up 1.2% from the prior quarter.

Analysis

Corbus Pharmaceuticals Holdings (CRBP) Share-based Compensation (2013 - 2025) Analysis & Trends

For the trailing twelve months through Sep 30, 2025, Share-based Compensation at Corbus Pharmaceuticals Holdings was $6.49 million, up 22.2% year-over-year; for FY2024, it was $6.15 million, up 77.1% from FY2023.

  • Annual Share-based Compensation shows a five-year compound annual growth rate of -12.5% (FY2019 to FY2024).
  • In prior years, Corbus Pharmaceuticals Holdings' Share-based Compensation was $3.47 million in FY2023 (-39.3%), $5.72 million in FY2022 (-39.7%), $9.48 million in FY2021 (-23.9%) and $12.46 million in FY2020 (+4.0%).
  • Quarterly Share-based Compensation has run from a low of $799,000 in Q4 2023 to a high of $2.6 million in Q3 2021 over five years.
  • On a year-over-year basis, Share-based Compensation increased in five of the last eight quarters, with growth averaging 44.9%.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q3 2024, with growth of 173.2%; the weakest was Q3 2022, with a decline of 48.2%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $1.56 million (Q2 2025), $1.71 million (Q1 2025) and $1.63 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 357.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 166.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 231.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 249.00 Mn
10 Corbus Pharmaceuticals Holdings 50.64 Mn -465.99 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1,582.00
Jun 30, 2025 1.56 Mn
Mar 31, 2025 1.71 Mn
Dec 31, 2024 1.63 Mn
Sep 30, 2024 2,243.00
Jun 30, 2024 1,288.00
Mar 31, 2024 982,000.00
Dec 31, 2023 799,000.00
Sep 30, 2023 821,000.00
Jun 30, 2023 823,000.00
Mar 31, 2023 1.03 Mn
Dec 31, 2022 1.27 Mn
Sep 30, 2022 1.35 Mn
Jun 30, 2022 1.51 Mn
Mar 31, 2022 1.59 Mn
Dec 31, 2021 1.79 Mn
Sep 30, 2021 2.60 Mn
Jun 30, 2021 2.51 Mn
Mar 31, 2021 2.58 Mn
Dec 31, 2020 2.34 Mn
API Access

Corbus Pharmaceuticals Holdings Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CRBP&period=max&api_key=YOUR_API_KEY